Short Interest in Sonova Holding (OTCMKTS:SONVY) Drops By 94.2%

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 3,402 shares, a drop of 94.2% from the May 31st total of 58,424 shares. Based on an average daily volume of 40,770 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.

Sonova Stock Up 0.6%

SONVY stock traded up $0.31 during midday trading on Thursday, hitting $48.05. The company’s stock had a trading volume of 19,187 shares, compared to its average volume of 23,576. The firm’s 50-day moving average is $48.59 and its 200-day moving average is $49.90. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. Sonova has a 12 month low of $42.26 and a 12 month high of $61.09.

Analyst Ratings Changes

SONVY has been the topic of several research reports. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research report on Wednesday, May 13th. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday. BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Finally, Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Sonova currently has an average rating of “Moderate Buy”.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.